
Seres Therapeutics MCRB
$ 7.07
-0.28%
Quarterly report 2025-Q3
added 11-05-2025
Seres Therapeutics Total Inventories 2011-2026 | MCRB
Annual Total Inventories Seres Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.6 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 29.6 M | 29.6 M | 29.6 M |
Quarterly Total Inventories Seres Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 53 M | 42 M | 29.6 M | 18.5 M | 5.34 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 53 M | 5.34 M | 29.7 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
39.1 K | $ 0.88 | 0.34 % | $ 6.47 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 22.41 | -1.15 % | $ 3.71 B | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.07 | -0.61 % | $ 435 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 22.47 | -3.54 % | $ 2.86 B | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.43 | -3.72 % | $ 381 M | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
22.9 M | - | - | $ 546 M | ||
|
Cara Therapeutics
CARA
|
2.82 M | - | -3.03 % | $ 260 M | ||
|
CASI Pharmaceuticals
CASI
|
1.91 M | - | - | $ 35.4 M | ||
|
BioXcel Therapeutics
BTAI
|
722 K | $ 1.04 | -1.9 % | $ 12.7 M | ||
|
ChemoCentryx
CCXI
|
851 K | - | - | $ 3.74 B |